The Korean paper links the rise to obesity drug use and extreme dieting among young adults.
Recap by typeshit. Full story at 조선일보.
A patient stopped Wegovy for weeks around surgery and asks others whether symptoms returned when they came off it.
One user says her period returned after two months on tirzepatide without medroxyprogesterone and asks others to compare.
She singles out products sold as retatrutide as especially dangerous, part of the growing pushback on gray-market peptide sellers.
In Touch Weekly reports the March 2025 death was caused by anaphylaxis and was Australia's first death of its kind linked to anti-aging drugs.
The pharmacists' group says the drug looks promising but urges patients to understand what they risk with unofficial sources, and points to its SafeMedication site.
The pharmacists' group points people to its SafeMedication site for a patient-friendly explainer on retatrutide and why unofficial sources are risky.
Loading…